Dare Bioscience Inc. (DARE)
Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
Bionano Genomics Inc (BNGO)
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
Trinity Biotech plc (TRIB)
Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service
Viatris Inc (VTRS)
GSK plc (GLAXF)
Daxor Corporation (DXR)
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
Cresco Labs Inc. (CRLBF)
Inotiv Inc. (NOTV)
Know Labs (KNW)
New Form 8-K - KNOW LABS, INC. Filed: 2025-08-07 AccNo: 0001654954-25-009164 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or …
Intellia Therapeutics Inc (NTLA)
New Form 8-K - Intellia Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104574 Size: 405 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Allurion Technologies Inc (ALUR)
Cabaletta Bio Inc (CABA)
Cronos Group Inc (CRON)
New Form 8-K - Cronos Group Inc. Filed: 2025-08-07 AccNo: 0001656472-25-000077 Size: 815 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits